title: [HIV-1 vaccination--is there hope?].
abstract: The HIV pandemic continues. Today the number of HIV-infected people is estimated to be 39.4 million. Despite huge efforts it is unlikely that there will be an efficient HIV vaccine available in the near future. Until now, only two phase III HIV vaccination trials have been performed in man. However, transmission could not be prevented. The hurdle for a rational approach to generate a vaccine is the still incomplete knowledge about HIV pathogenesis and the high rate of mutations of HIV. In this review we discuss the distinct aspects of the immune response, which could be exploited for HIV vaccine strategies and describe current vaccine approaches.
authors.affiliation: Abteilung für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich, Zürich. roberto.speck@usz.ch
authors.forename: R F
authors.initials: RF
authors.lastname: Speck
authors.forename: C
authors.initials: C
authors.lastname: Brander
authors.forename: T M
authors.initials: TM
authors.lastname: Kündig
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D032541:Mass Vaccination / Q000379:methods*; D014611:Vaccination / Q000379:methods* / Q000639:trends*
chemical_list: D016915:AIDS Vaccines